Rxsight Inc (RXST) financials

NASDAQ · Health Care

$4.87 -3.56% Close Oct 30, 2026 Live

Rxsight revenue and earnings by year

Rxsight's revenue was $134 million in the fiscal year to December 31, 2025, down 3.9% from the year before. Net income was -$38.9 million, -29.0% of revenue. Since the fiscal year to December 31, 2019, revenue has grown 97.8% a year on average.

RevenueNet income
$0$100M
2019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 7 fiscal years

In millions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Revenue134140894923152
Revenue growth-3.9%57.1%81.8%116.9%53.9%555.0%—
Gross profit10399542152-2
Gross margin76.6%70.7%60.4%43.5%20.0%11.6%-81.2%
Operating income-48-37-50-63-53-35-46
Operating margin-35.8%-26.3%-56.2%-129.2%-233.6%-241.3%-2055.8%
Net income-39-27-49-67-4928126
Net margin-29.0%-19.6%-54.6%-136.2%-215.5%187.9%5632.3%
Diluted EPS-$0.95-$0.71-$1.41-$2.41———
Free cash flow-19-22-46-61-47-38-44

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open RXST in Markets.

How Rxsight makes money

Revenue by segment in the quarter to June 30, 2026, as the company reports it.

SegmentRevenueShare
Rxlal$24.5M72.6%
License & Collaboration Revenue$6.50M19.3%
Service Warranty Service Contracts & Accessories$1.40M4.2%
LDD$1.34M4.0%

See also: RXST returns

No forecast, no recommendation. This page describes Rxsight Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.